Muranaka K - Search Results

1

Subconjunctival administration of bucillamine suppresses choroidal neovascularization in rat.

Yanagi Y, Tamaki Y, Obata R, Muranaka K, Homma N, Matsuoka H, Mano H. Yanagi Y, et al. Among authors: muranaka k. Invest Ophthalmol Vis Sci. 2002 Nov;43(11):3495-9. Invest Ophthalmol Vis Sci. 2002. PMID: 12407161

2

Subconjunctival doxifluridine administration suppresses rat choroidal neovascularization through activated thymidine phosphorylase.

Yanagi Y, Tamaki Y, Inoue Y, Obata R, Muranaka K, Homma N. Yanagi Y, et al. Among authors: muranaka k. Invest Ophthalmol Vis Sci. 2003 Feb;44(2):751-4. doi: 10.1167/iovs.02-0222. Invest Ophthalmol Vis Sci. 2003. PMID: 12556409

3

COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.

Takahashi H, Yanagi Y, Tamaki Y, Uchida S, Muranaka K. Takahashi H, et al. Among authors: muranaka k. Biochem Biophys Res Commun. 2004 Dec 10;325(2):461-6. doi: 10.1016/j.bbrc.2004.10.054. Biochem Biophys Res Commun. 2004. PMID: 15530415

4

Suppression of laser-induced choroidal neovascularization by oral administration of SA3443 in mice.

Muranaka K, Yanagi Y, Tamaki Y, Takahashi H, Usui T, Ohashi K, Matsuoka H, Senda T. Muranaka K, et al. FEBS Lett. 2005 Nov 7;579(27):6084-8. doi: 10.1016/j.febslet.2005.09.079. Epub 2005 Oct 7. FEBS Lett. 2005. PMID: 16229837 Free article.

5

Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.

Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M. Muranaka K, et al. Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4547-52. doi: 10.1167/iovs.05-1432. Invest Ophthalmol Vis Sci. 2006. PMID: 17003451

6

Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase.

Kami J, Muranaka K, Yanagi Y, Obata R, Tamaki Y, Shibuya M. Kami J, et al. Among authors: muranaka k. Jpn J Ophthalmol. 2008 Mar-Apr;52(2):91-98. doi: 10.1007/s10384-007-0506-6. Epub 2008 Apr 30. Jpn J Ophthalmol. 2008. PMID: 18626731

7

Transpupillary thermotherapy for treatment of exudative age-related macular degeneration in Japanese patients.

Atarashi T, Tamaki Y, Inoue Y, Obata R, Muranaka K, Yanagi Y. Atarashi T, et al. Among authors: muranaka k. Eye (Lond). 2004 Jun;18(6):615-8. doi: 10.1038/sj.eye.6700733. Eye (Lond). 2004. PMID: 14739926

8

Contribution of bone-marrow-derived cells to choroidal neovascularization.

Takahashi H, Yanagi Y, Tamaki Y, Muranaka K, Usui T, Sata M. Takahashi H, et al. Among authors: muranaka k. Biochem Biophys Res Commun. 2004 Jul 23;320(2):372-5. doi: 10.1016/j.bbrc.2004.05.177. Biochem Biophys Res Commun. 2004. PMID: 15219837

9

[A case of jejunal adenocarcinoma with anxiety disorder].

Iwahashi N, Tashiro S, Kanazawa H, Sugawara T, Takahashi H, Muranaka K, Kiuchi Y, Hiwatari N, Akashi T, Muto D. Iwahashi N, et al. Among authors: muranaka k. Nihon Naika Gakkai Zasshi. 1994 Jun 10;83(6):984-5. Nihon Naika Gakkai Zasshi. 1994. PMID: 7964052 Japanese. No abstract available.

10

Conjunctival haemangioma in an elderly patient.

Muranaka K, Kunimatsu S, Kaji Y, Joko S, Kato S, Numaga J. Muranaka K, et al. Eye (Lond). 1999 Dec;13 ( Pt 6):790. doi: 10.1038/eye.1999.230. Eye (Lond). 1999. PMID: 10707147 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters